Your position:m.limatoxi.com >> EN >> EN >> Formulation >> The first in the world! Huadong Pharmaceuticals new FRα target ADC was approved by the FDA >> article
 
The first in the world! Huadong Pharmaceuticals new FRα target ADC was approved by the FDA
Editor:xuezhe    Clicks:0    Date:2022-11-17 17:21:31
Keyword: FDA
Healthoo Information:
The first in the world! Huadong Pharmaceuticals new FRα target ADC was approved by the FDA
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • FDA Success Stories CDE Recommendations: How MIDD Accelerates Drug Dis...
  • The worlds first Upadatinib extended-release tablets approved by FDA f...
  • Sodium thiosulfate has been approved by the FDA to reduce hearing loss...
  • FDA approves ibrutinib for chronic graft-versus-host disease in childr...
  • FDA Issues Drug Statement, Mercks Hypoglycemic Drug Sitagliptin Detect...
  • Upadatinibs launch accelerated: Crohns disease has simultaneously subm...
  • FDA Breakthrough Therapy Designation for Topical Vitamin A Derivatives...
  • AstraZenecas Ultomiris Third Indication Approved by US FDA!
  • New Drugs Approved by FDA in February 2022
  • Nature: FDA Approval of New Drugs Sales Forecast in 2021
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map